Yeah, they are playing the market cap numbers, 164M market cap, they probably feel they can wait just a little longer. We will see once the pivotal mono trial gets approved if they jump. NP has mentioned BP meetings. I'm sure they are staying on top of the data. When cydy hits its inflection point, BP will start sweating. Mono has the possibility to take a large part of their market away, add in PReP, cancer, gvhd, nash. If they don't do the buyout, they will look back with great regret one day soon.